New study highlights the urgent need for typhoid vaccination in sub-Saharan Africa

SPACs might nev­er ful­ly go away if the am­bi­tions of three new health­care-fo­cused shops have any sway. As ini­tial pub­lic of­fer­ings are far and few

Af­ter a sleepy few months, the biotech IPO mar­ket is wak­ing up thanks to back-to-back-to-back list­ings. On­col­o­gy-fo­cused Bicara Ther­a­peu­tics, au­toim­mune start­up Zenas Bio­Phar­ma and meta­bol­ic